Literature DB >> 6983470

Anti-albumin antibodies in sera of patients with liver disease.

N Tamura, T Suou, C Hirayama.   

Abstract

We used passive haemagglutination assay to examine sera from 77 patients with various liver diseases for the presence of antibodies to human serum albumin (HSA), bovine serum albumin (BSA) ans ovalbumin (OA). The antibody titre to BSA was higher than that to OA or HSA. Of the examined diseases, in chronic active hepatitis and liver cirrhosis, the titre and incidence of anti-BSA antibody were highest. There was a positive correlation between anti-BSA antibody and serum gamma-globulin level. Sephadex G-200 column chromatography and immunoelectrophoresis revealed that the anti-BSA antibody belonged to the IgM class.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983470     DOI: 10.1007/BF02774725

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  25 in total

1.  ANTI-BOVINE SERUM ALBUMIN AND ANTI-ALPHA LACTALBUMIN IN THE SERUM OF CHILDREN AND ADULTS.

Authors:  R M ROTHBERG; R S FARR
Journal:  Pediatrics       Date:  1965-04       Impact factor: 7.124

2.  Immunochemical properties of the cross-reactions between anti-BSA and heterologous albumins.

Authors:  W O WEIGLE
Journal:  J Immunol       Date:  1961-11       Impact factor: 5.422

3.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

Authors:  H C Thomas; R N McSween; R G White
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

4.  Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

Authors:  M Bjorneboe; H Prytz; F Orskov
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

5.  Bacterial and dietary antibodies in liver disease.

Authors:  D R Triger; M H Alp; R Wright
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

6.  Immune complexes in acute and chronic liver disease.

Authors:  H C Thomas; D De Villiers; B Potter; H Hodgson; S Jain; D P Jewell; S Sherlock
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

7.  A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg.

Authors:  M Imai; Y Yanase; T Nojiri; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

8.  Differences in intrahepatic portal-systemic shunting in alcoholic and nonalcoholic liver disease as assessed by liver scan, portal pressure, and E. coli antibodies.

Authors:  D R Triger; T D Boyer; A G Redeker; T B Reynolds; A D Waxman
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

9.  Antibodies to human albumin in cirrhotic sera.

Authors:  S Hauptman; T B Tomasi
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

10.  ACTIVITY OF DISSOCIATED AND REASSOCIATED 19S ANTI-GAMMA-GLOBULINS.

Authors:  R E SCHROHENLOHER; H G KUNKEL; T B TOMASI
Journal:  J Exp Med       Date:  1964-12-01       Impact factor: 14.307

View more
  6 in total

1.  Cellular sensitivity to collagen in liver disease.

Authors:  H Sawada; T Suou; C Hirayama
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

2.  The Japanese Society of Gastroenterology. Proceedings of the 71st general meeting. Sapporo, Japan, May 22-24, 1985.

Authors: 
Journal:  Gastroenterol Jpn       Date:  1986-04

3.  Antibodies to human albumin epitopes in type 1 (insulin-dependent) diabetes mellitus.

Authors:  R Mangili; G C Viberti; D Vergani
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

4.  A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus.

Authors:  J Norris; M Pietropaolo
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

5.  Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease.

Authors:  C J Darroch; R M Barnes; J Dawson
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

6.  Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.

Authors:  Josephine Nehring; Lucia A Schirmbeck; Justa Friebus-Kardash; Denise Dubler; Uyen Huynh-Do; Carlo Chizzolini; Camillo Ribi; Marten Trendelenburg
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.